Besides, the sensitivity and specificity values of APEX1 for CCA diagnosis were compared to those of currently used biomarkers, carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), and alkaline phosphatase (ALP). This evidence concerns the gene CEACAM5 and cholangiocarcinoma.